17,881 resources
By Version
By Realm
Start Prev Rows 8800 - 9000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.fhir.uv.order-catalog | R5 | example-reasons-for-order | All Valid Reasons for Ordering a Lab Service | trial-use | 2 | oo | 2019-12 | uv | sct |
hl7.fhir.nl.zorgviewer | R3 | bronsysteem-zorgaanbieder | Bronsysteem Zorgaanbieder | active | 2025-08 | nl | ietf | ||
hl7.terminology | R5 | v3-BuccalMucosaRoute | BuccalMucosaRoute | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance | active | 2024-06 | us | vsac | ||
hl7.fhir.us.mcode | R4 | mcode-lymphoma-stage-bulky-modifier-vs | Lymphoma Stage Bulky Modifier Value Set | active | cic | 2025-02 | us | sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.9.1--20200901000000 | BurgerlijkeStaatCodelijst | active | nl | tho | |||
hl7.fhir.us.vdor | R4 | vdor-bystanders-present-vs | VDOR Bystander(s) Present | informative | pher | 2025-06 | us | fhir | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.6--20200901000000 | VerrichtingTypeCBVCodelijst | active | nl | oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.3221.8.11 | Medication Product Form | active | 2024-06 | us | ncit | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test | active | 2022-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.152 | Body Temperature | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.159 | Body Weight | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1104.10 | Medicare FFS Payer | active | 2023-02 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1104.12 | Medicare Advantage Payer | active | 2023-02 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.666.5.2363 | Creatinine Lab Test | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry | active | 2023-02 | us | loinc | ||
hl7.fhir.uv.tools | R5 | CDSActionType | CDSActionType Codes ValueSet | informative | 1 | fhir | 2025-08 | uv | fhir |
hl7.fhir.uv.tools | R5 | CDSIndicator | CDSIndicator Codes ValueSet | informative | 1 | fhir | 2025-08 | uv | fhir |
hl7.fhir.uv.tools | R5 | CDSLinkType | CDSLinkType Codes ValueSet | informative | 1 | fhir | 2025-08 | uv | fhir |
hl7.fhir.uv.tools | R5 | CDSSelectionBehavior | CDSSelectionBehavior Codes ValueSet | informative | 1 | fhir | 2025-08 | uv | fhir |
ch.fhir.ig.ch-term | R4 | CHAllergyIntoleranceValueSet | CH AllergyIntolerance | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-term | R4 | CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-term | R4 | CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-term | R4 | CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-ig | R4 | ch-ig-example-sct | CH IG Example SNOMED CT | draft | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-ig | R4 | ch-ig-example-translation | CH IG Example Translation | draft | 2025-06 | ch | internal | ||
ch.fhir.ig.ch-ig | R4 | ch-ig-example | CH IG Example | draft | 2025-06 | ch | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.36 | All Metastatic Sites | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.43 | Breast Cancer | active | 2023-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.44 | Breast Cancer | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.15 | All Metastatic Sites | active | 2023-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.35 | All Metastatic Sites | active | 2023-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.39 | Locoregional Breast Cancer | active | 2023-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.38 | Locoregional Breast Cancer | active | 2023-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.37 | Locoregional Breast Cancer | active | 2023-10 | us | sct | ||
hl7.fhir.us.davinci-pct | R4 | PCTGFECMSPOS | PCT GFE CMS Place of Service Value Set | trial-use | fm | 2025-08 | us | cms | |
signal.core.r4 | R4 | place-of-service | Place Of Service | draft | 1 | pa | us | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.17.2.4--20200901000000 | AfdelingSpecialismeCodelijst | active | nl | oid | |||
ch.fhir.ig.ch-crl | R4 | nkrs-cogallstaging | NKRS - COG ALL Staging | active | 2022-02 | ch | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure | active | 2021-03 | us | sct | ||
hl7.fhir.us.davinci-pct | R4 | USClaimMedicalProductOrServiceCodes | Claim Medical Product or Service Value Set | trial-use | fm | 2025-08 | us | cpt cms tho | |
hl7.fhir.us.davinci-pct | R4 | PCTGFEItemCptHcpcsVS | PCT GFE Item CPT - HCPCS Value Set | trial-use | fm | 2025-08 | us | cpt cms | |
hl7.terminology | R5 | cpt-modifiers | AMA CPT Modifier Codes | active | vocab | 2023-08 | uv | cpt | |
hl7.fhir.us.icsr-ae-reporting | R4 | COVID19VaccineCodeVS | COVID-19 Vaccine Codes | draft | 2023-08 | us | ndc | ||
hl7.fhir.us.registry-protocols | R4 | CardiacCTA | CTA Heart and Coronary arteries | active | cic | 2023-11 | us | loinc | |
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.22 | CVX Vaccines Administered Complete Set | active | 2024-06 | us | cvx | ||
hl7.fhir.us.icsr-ae-reporting | R4 | VaccineCodeVS | Vaccine Codes | draft | 2023-08 | us | fhir | ||
hl7.fhir.us.icsr-ae-reporting | R4 | InfluenzaVaccineCodeVS | Influenza Vaccine Codes | draft | 2023-08 | us | ndc | ||
hl7.fhir.us.breast-radiology | R4 | CalcificationDistributionVS | CalcificationDistribution ValueSet | active | 2022-12 | us | sct | ||
hl7.eu.fhir.idea4rc | R4 | vs-calcest-eu-i4rc | Calculated|Estimated | draft | 2025-07 | eu | fhir sct | ||
hl7.eu.fhir.pcsp | R4 | vs-calcest-eu-pcsp | Calculated|Estimated | draft | 2025-08 | eu | sct tho | ||
hl7.fhirpath | R4 | calendar-units | Calendar Duration Units ValueSet | active | 2024-02 | uv | fhir | ||
hl7.fhir.cl.minsal.nid | R4 | VScalificacionPrevisional | Calificación Previsional | active | 2023-01 | cl | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) | active | 2023-06 | us | loinc | ||
hl7.fhir.cl.clcore | R4 | VSNombreCampana | Campañas de Vacunación | active | 2022-06 | cl | internal | ||
hl7.fhir.cl.corecl | R4 | VSNombreCampana | Campañas de Vacunación | active | 2022-06 | cl | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.16 | All Metastatic Sites | active | 2023-10 | us | icd | ||
hl7.fhir.be.pss | R4 | CandidaCodes | Candida Codes | active | 2025-07 | be | sct | ||
fhir.cdc.opioid-cds-r4 | R4 | cannabinoid-urine-drug-screening-tests | Cannabinoid class urine drug screening | active | 2023-05 | us | loinc | ||
hl7.terminology | R5 | v3-MedicationCap | MedicationCap | active | 2014-03 | uv | tho | ||
ca.on.oh.mha-pds | R4 | Valueset.ca-on-mha-CitizenshipStatus | Citizenship Status | active | 2022-08 | ca | sct tho | ||
hl7.fhir.us.registry-protocols | R4 | CardiacCTAResults | Cardiac CTA Results | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.us.registry-protocols | R4 | CardiacInstabilityType | Cardiac Instability Type | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.be.terminology | R4 | be-vs-care-location | BeVSCareLocation | active | 2021-01 | be | |||
hl7.fhir.be.vaccination | R4 | be-vs-care-location | BeVSCareLocation | active | 1 | 2025-03 | be | internal | |
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-care-location | Care Location Value Set | active | 2021-01 | internal | |||
hl7.fhir.sami.core | R4 | Admission_priority | Prioridade de admissão | active | 2022-02 | sami | |||
hl7.terminology | R5 | v3-ActAdjudicationGroupCode | ActAdjudicationGroupCode | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.rfi-ig | R5 | rfi-category-subcategory | RFICategoryAndSubcategory | draft | 2025-06 | uv | fhir | ||
hl7.fhir.us.pco | R4 | pco-categories | Person-Centered Categories | draft | 2 | pc | 2025-08 | us | fhir |
hl7.fhir.us.directory-query | R4 | OrgAliasTypeVS | Organization Alias Typ Value Sete | active | 2022-12 | us | fhir | ||
hl7.fhir.us.ndh | R4 | OrgAliasTypeVS | Organization Alias Type Value Sete | trial-use | pa | 2025-07 | us | tho | |
hl7.fhir.us.directory-query | R4 | InsurancePlanTypeVS | Insurance Plan Type Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex-plan-net | R4 | InsurancePlanTypeVS | Insurance Plan TypeVS | trial-use | fm | 2025-02 | us | fhir | |
hl7.fhir.us.directory-query | R4 | OrgTypeVS | Organization Type Value Set | active | 2022-12 | us | fhir | ||
hl7.fhir.us.davinci-pdex | R4 | OrgTypeVS | Organization Type VS | informative | fm | 2025-06 | us | fhir | |
hl7.fhir.us.davinci-pdex-plan-net | R4 | OrgTypeVS | Organization Type VS | trial-use | fm | 2025-02 | us | fhir | |
hl7.fhir.us.ndh | R4 | OrgTypeVS | Organization Type Value Set | trial-use | pa | 2025-07 | us | fhir tho | |
hl7.fhir.uv.smart-app-launch | R4 | user-access-category | User Access Category Value Set | active | fhir | 2023-03 | uv | tho | |
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-amendment-scope-enrollment-vs | Study Amendment Scope Enrollment Value Set | trial-use | 2 | brr | 2025-07 | uv | ncit |
hl7.fhir.us.davinci-pct | R4 | PCTBenefitBalanceCategoryVS | PCT benefitBalance.category codes | trial-use | fm | 2025-08 | us | x12 | |
hl7.eu.fhir.idea4rc | R4 | vs-surgicalProcedureCategory-eu-i4rc | Surgical Procedure Category | active | 2025-07 | eu | |||
hl7.fhir.be.problem | R4 | ProblemCategoryVS | Problem Category Value Set | active | 2025-05 | be | |||
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set | active | cgp | 2025-02 | us | sct | |
hl7.fhir.au.ereq | R4 | au-erequesting-communicationrequest-patientcategory | AU eRequesting CommunicationRequest Patient Category | draft | 0 | 2025-02 | au | tho | |
hl7.fhir.cl.minsal.eis | R4 | VSUCursoAprobado | Ultimo Curso Aprobado | active | 2022-01 | cl | internal | ||
hl7.fhir.us.registry-protocols | R4 | IntraAndPostEvents | Cath PCI qualified list of Events | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.be.allergy | R4 | be-causativeagent | BeCausativeAgent | active | 1 | 2025-07 | be | sct | |
hl7.fhir.uv.order-catalog | R5 | example-normal-contexts-vitamin-d | Contextes de remboursement du dosage de la vitamine D | trial-use | 2 | oo | 2019-12 | uv | sct |
hl7.terminology | R5 | v3-CecostomyRoute | CecostomyRoute | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4502 | Ceftriaxone all code types | active | 2024-05 | us | rx | ||
hl7se.fhir.base | R4 | SEBaseHOSPLegitimationsYrkeVS | ValueSet for certification occupation from HOSP | active | 2025-06 | se | oid | ||
hl7.fhir.us.vrdr | R4 | vrdr-certifier-types-vs | Certifier Types Value Set | active | pher | 2024-10 | us | sct tho | |
hl7.terminology | R5 | v3-CervicalRoute | CervicalRoute | active | 2014-03 | uv | tho | ||
openehr.base | R5 | character-sets | Character Set | informative | 3 | fhir | 2024-04 | uv | |
hl7.terminology | R5 | v3-ActTransportationModeCode | ActTransportationModeCode | active | 2014-03 | uv | tho | ||
hl7.eu.fhir.idea4rc | R4 | chemotherapy-info-eu-i4rc | Chemotherapy Info | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | chemo-units-eu-i4rc | Chemotherapy cumulative dose units | draft | 2025-07 | eu | ucum | ||
hl7.eu.fhir.pcsp | R4 | ChemoUnitsVs | Chemotherapy cumulative dose units | draft | 2025-08 | eu | ucum | ||
hl7.fhir.us.registry-protocols | R4 | ChestPainSymptomAssessment | Chest Pain Symptom Assessment | active | cic | 2023-11 | us | fhir sct | |
hl7.terminology | R5 | v3-Chew | Chew | active | 2014-03 | uv | tho | ||
hl7.fhir.be.pss | R4 | ChlamydiaCodes | Chlamydia Codes | active | 2025-07 | be | sct icd | ||
hl7.terminology | R5 | v3-GTSAbbreviationHolidaysChristianRoman | GTSAbbreviationHolidaysChristianRoman | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | chromosome-human | chromosome-human | draft | 1 | cg | 2020-02 | uv | tho |
hl7.fhir.us.registry-protocols | R4 | ChronicLungDisease | Chronic Lung Disease | active | cic | 2023-11 | us | sct loinc | |
hl7.terminology | R5 | citation-artifact-classifier | Citation Artifact Classifier | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.fhir.uv.extensions.r3 | R3 | citation-artifact-classifier | Citation Artifact Classifier | trial-use | 1 | fhir | 2021-03 | uv | fhir |
hl7.terminology | R5 | citation-classification-type | Citation Classification Type | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.terminology | R5 | cited-artifact-contribution-type | Cited Artifact Contribution Type | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.terminology | R5 | cited-artifact-classification-type | Cited Artifact Classification Type | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.terminology | R5 | cited-artifact-status-type | Cited Artifact Status Type | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.terminology | R5 | v3-RoleClassCitizen | RoleClassCitizen | active | 2014-03 | uv | tho | ||
fhir.org.nz.ig.base | R4 | citizenship-status | NZ Citizenship status | active | 2025-06 | us | |||
hl7.fhir.fr.core | R4 | fr-core-vs-civility-exercice-rass | FR Core ValueSet Civility exercice RASS | informative | 0 | fhir | 2024-09 | fr | |
hl7.fhir.fr.core | R4 | fr-core-vs-civility-rass | FR Core ValueSet Civility RASS | informative | 0 | fhir | 2024-09 | fr | |
hl7.terminology | R5 | claim-careteamrole | Claim Care Team Role Codes | active | 1 | fm | 2024-04 | uv | tho |
fhir.ops-esavi | R4 | ClasificacionDesenlaceVS | Código desenlaces tras ESAVI | active | 2021-03 | us | internal | ||
hl7.terminology | R5 | v3-ActClassDiagnosticImage | ActClassDiagnosticImage | active | 2014-03 | uv | tho | ||
openehr.base | R5 | proportion-kind | PROPORTION_KIND | informative | 3 | fhir | 2023-06 | uv | |
hl7.terminology | R5 | v3-EntityClassImagingModality | EntityClassImagingModality | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | signal-filerepo-classification | Signal FileRepo Classification | draft | 2023-09 | us | loinc | ||
ee.hl7.fhir.base.r5 | R5 | ee-occupation | Occupation | draft | 2023-08 | ee | internal | ||
hl7.fhir.it.terminology | R4 | istat-titoloStudio | ISTAT - Titolo Studio | active | 2025-06 | it | internal | ||
hl7.fhir.it.terminology | R4 | istat-professione | ISTAT - Professioni | active | 2025-06 | it | internal | ||
hl7.terminology | R5 | v3-EntityClass | EntityClass | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | questionnaire-dacods-source-of-illicit-drugs | Questionnaire DACODS Source Of Illicit Drugs | draft | 1 | pa | us | ||
hl7.fhir.us.pacio-adi | R4 | ADIPersonalAndLegalRelationshipRoleTypeVS | Personal And Legal Relationship Role Type | trial-use | 2 | pe | 2025-08 | us | tho |
hl7.fhir.us.pacio-adi | R4 | ADIInterventionPreferencesOrdinalVS | Intervention Preferences - Ordinal | trial-use | 2 | pe | 2025-08 | us | loinc |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-clinical-importance | Clinical Importance of Outcome | draft | 2022-09 | uv | internal | ||
nhsd.assets.stu3 | R3 | CareConnect-ReactionEventSeverity-1 | AllergyIntoleranceSeverity | draft | 3 | pc | 2017-04 | fhir | |
NHSDigital.FHIR.STU3 | R3 | CareConnect-ReactionEventSeverity-1 | AllergyIntoleranceSeverity | active | 3 | pc | 2017-04 | fhir | |
hl7.fhir.uv.eyecare | R4 | conditions | Ophthalmology Condition ICD10 and SNOMED codes ValueSet | active | 2019-05 | uv | sct icd | ||
hl7.fhir.ca.baseline | R4 | healthconcerncode | Health Concern Code | draft | 2025-05 | ca | |||
ee.hl7.fhir.base.r5 | R5 | ee-clinical-specialty | Clinical Specialty | draft | 2023-08 | ee | sct | ||
ee.fhir.terminology | R5 | clinical-specialty | Clinical Specialty | active | 2025-06 | ee | sct | ||
hl7.fhir.us.breast-radiology | R4 | rde1558-location | RDE1558 Location | draft | 2022-12 | us | fhir | ||
hl7.terminology | R5 | v3-xEncounterParticipant | x_EncounterParticipant | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xServiceEventPerformer | x_ServiceEventPerformer | active | 2014-03 | uv | tho | ||
fhir.kenyaPSIG | R4 | CodeSystemsVS | Code Systems ValueSet | draft | 2025-07 | us | internal | ||
hl7.fhir.us.davinci-pct | R4 | PCTGFETaskRelationship | PCT GFE Task Relationship | trial-use | fm | 2025-08 | us | tho | |
hl7.fhir.us.mcode | R4 | mcode-tumor-size-method-vs | Tumor Size Method Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.terminology | R5 | v3-CaseTransmissionMode | CaseTransmissionMode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ExposureMode | ExposureMode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActPaymentCode | ActPaymentCode | active | 2014-03 | uv | tho | ||
hl7.fhir.us.carin-bb | R4 | NCPDPRejectCode | NCPDP Reject Code Value Set | trial-use | fm | 2025-02 | us | tho | |
hl7.fhir.us.carin-bb | R4 | NCPDPPrescriptionOriginCode | NCPDP Prescription Origin Code Value Set | trial-use | fm | 2025-02 | us | tho | |
hl7.terminology | R5 | v3-LivingSubjectProductionClass | LivingSubjectProductionClass | active | 2014-03 | uv | tho | ||
hl7.fhir.us.carin-bb | R4 | NCPDPDispensedAsWrittenOrProductSelectionCode | NCPDP Dispense As Written (DAW)/Product Selection Code Value Set | trial-use | fm | 2025-02 | us | tho | |
hl7.fhir.us.carin-bb | R4 | NCPDPCompoundCode | NCPDP Compound Code Value Set | trial-use | fm | 2025-02 | us | tho | |
hl7.terminology | R5 | guide-parameter-code | GuideParameterCode | draft | fhir | 2020-02 | uv | tho | |
hl7.fhir.be.problem | R4 | ProblemCodeVS | Problem Code Value Set | active | 2025-05 | be | |||
hl7.terminology | R5 | object-role | AuditEventEntityRole | active | 3 | sec | 2024-06 | uv | tho |
hl7.fhir.us.core | R4 | us-core-problem-or-health-concern | US Core Problem or Health Concern | trial-use | 3 | cgp | 2022-09 | us | fhir tho |
hl7.fhir.us.breastcancer | R3 | shr-core-YesNoUnknownVS | BC YesNoUnknownVS ValueSet | draft | 2018-08 | us | fhir | ||
hl7.terminology | R5 | v3-ActDietCode | ActDietCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationEligibilityIndicatorValue | ObservationEligibilityIndicatorValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActFinancialStatusObservationValue | ActFinancialStatusObservationValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationIncomeValue | ObservationIncomeValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationHealthStatusValue | ObservationHealthStatusValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationSocioEconomicStatusValue | ObservationSocioEconomicStatusValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationLivingSituationValue | ObservationLivingSituationValue | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.114222.4.11.1066 | Healthcare Provider Taxonomy | active | 2024-06 | us | nucc | ||
hl7.terminology | R5 | v3-CodeSystem | CodeSystem | retired | 2014-03 | uv | tho | ||
hl7.terminology | R5 | artifact-url-classifier | Artifact Url Classifier | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.fhir.us.vrdr | R4 | vrdr-place-of-death-vs | Place of Death ValueSet | active | pher | 2024-10 | us | sct tho | |
hl7.terminology | R5 | v2-0970 | hl7VS-onlineVerificationResult | active | 2019-12 | uv | tho | ||
hl7.fhir.uv.pocd | R4 | operating-mode | Operating Mode | draft | 2020-05 | uv | fhir | ||
hl7.fhir.uv.pocd | R4 | kind-of-relation | Kind | draft | 2020-05 | uv | fhir | ||
hl7.fhir.uv.pocd | R4 | safety | Safety | draft | 2020-05 | uv | fhir | ||
hl7.fhir.uv.pocd | R4 | metric-availability | Metric Availability | draft | 2020-12 | uv | fhir | ||
ch.fhir.ig.ch-epr-fhir | R4 | ChPdqmMoreAttributesRequested | CH PDQm ValueSet More Attributes Requested | active | 2025-05 | ch | oid | ||
ch.fhir.ig.ch-epr-mhealth | R4 | ChPdqmMoreAttriburesRequested | CH PDQm ValueSet More Attributes Requested | active | 2024-03 | ch | oid | ||
hl7.fhir.us.davinci-ra | R4 | coding-gap-remark | Coding Gap Remark | trial-use | 2 | cqi | 2025-07 | us | fhir |
hl7.fhir.us.davinci-pct | R4 | PCTContributorTaskStatusCodes | Provider GFE Contributor Task Status Codes | trial-use | fm | 2025-08 | us | fhir | |
hl7.fhir.us.davinci-pct | R4 | PCTCoordinationTaskStatusCodes | GFE Coordination Task Status Codes | trial-use | fm | 2025-08 | us | fhir | |
hl7.fhir.us.davinci-crd | R4 | cardActions | CDS Hooks Card Suggestion Action Types Value Set | trial-use | 4 | fm | 2025-08 | us | fhir |
hl7.fhir.us.dental-data-exchange | R4 | dental-procedure-codes-vs | Dental Procedure Codes Value Set | draft | 2025-04 | us | |||
hl7.fhir.us.davinci-crd | R4 | billingCodes | CRD Billing Codes Value Set | trial-use | 4 | fm | 2025-08 | us | cpt rx cms |
ehealthplatform.be.r4.federalprofiles | R4 | be-allergyintolerancecode | BeAllergyIntoleranceCode | active | internal | ||||
hl7.fhir.be.allergy | R4 | be-vs-allergyintolerance-type | BeVSAllergyIntoleranceType | active | 2025-07 | be | sct | ||
ehealthplatform.be.r4.federalprofiles | R4 | be-causativeagent | BeCausativeAgent | active | sct | ||||
hl7.fhir.be.allergy | R4 | be-riskmanifestation | BeRiskManifestation | active | 1 | 2025-07 | be | sct | |
ehealthplatform.be.r4.federalprofiles | R4 | be-riskmanifestation | BeRiskManifestation | active | sct | ||||
hl7.fhir.be.allergy | R4 | be-noallergy | BeNoAllergy | active | 1 | 2025-07 | be | sct | |
ehealthplatform.be.r4.federalprofiles | R4 | be-noallergy | BeNoAllergy | active | sct | ||||
hl7.fhir.be.core-clinical | R4 | be-vs-score | Score Value Set | active | 1 | 2020-10 | be | internal sct | |
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-score | Score Value Set | active | 2020-10 | internal sct | |||
fhir.outburn.co.il | R4 | diagnostic-procedures | diagnostic procedures during pregnencies codes | draft | us | sct | |||
fhir.outburn.co.il | R4 | amniotic-fluid-index | Codes for Amniotic Fluid Index | draft | us | sct | |||
hl7.fhir.uv.saner | R4 | ConfirmedCOVID19Diagnoses | Confirmed COVID-19 Diagnosis Values | active | pher | 2024-05 | uv | sct icd | |
hl7.terminology | R5 | v3-ActDetectedIssueManagementCode | ActDetectedIssueManagementCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActAdministrativeDetectedIssueManagementCode | ActAdministrativeDetectedIssueManagementCode | active | 2014-03 | uv | tho | ||
hl7.fhir.eu.imaging-manifest-r5 | R5 | media-view | Media View types - placeholder for cross-version extension | draft | 2025-07 | eu | sct | ||
hl7.fhir.eu.imaging-r5 | R5 | media-view | Media View types - placeholder for cross-version extension | draft | 2025-08 | eu | sct |